19-36719965-C-G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001322917.1(ZNF567):​c.1241C>G​(p.Thr414Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T414I) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 33)

Consequence

ZNF567
NM_001322917.1 missense

Scores

1
1
16

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.575

Publications

0 publications found
Variant links:
Genes affected
ZNF567 (HGNC:28696): (zinc finger protein 567) Predicted to enable DNA-binding transcription factor activity and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
ZNF850 (HGNC:27994): (zinc finger protein 850) Predicted to enable DNA-binding transcription activator activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.2476342).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001322917.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ZNF567
NM_001322917.1
MANE Select
c.1241C>Gp.Thr414Ser
missense
Exon 6 of 6NP_001309846.1Q8N184-3
ZNF567
NM_001387759.1
c.1310C>Gp.Thr437Ser
missense
Exon 7 of 7NP_001374688.1
ZNF567
NM_001300979.2
c.1241C>Gp.Thr414Ser
missense
Exon 6 of 6NP_001287908.1Q8N184-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ZNF567
ENST00000682579.1
MANE Select
c.1241C>Gp.Thr414Ser
missense
Exon 6 of 6ENSP00000507048.1Q8N184-3
ZNF567
ENST00000360729.8
TSL:1
c.1148C>Gp.Thr383Ser
missense
Exon 4 of 4ENSP00000353957.3Q8N184-1
ZNF567
ENST00000585696.5
TSL:1
c.1148C>Gp.Thr383Ser
missense
Exon 3 of 3ENSP00000467379.1Q8N184-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
34
GnomAD4 genome
Cov.:
33

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.64
BayesDel_addAF
Benign
-0.25
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Benign
0.043
T
Eigen
Benign
-0.32
Eigen_PC
Benign
-0.31
FATHMM_MKL
Benign
0.0010
N
LIST_S2
Benign
0.081
T
M_CAP
Benign
0.0088
T
MetaRNN
Benign
0.25
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.2
L
PhyloP100
-0.57
PrimateAI
Benign
0.47
T
PROVEAN
Benign
-1.9
N
REVEL
Benign
0.072
Sift
Benign
0.15
T
Sift4G
Benign
0.28
T
Polyphen
0.024
B
Vest4
0.22
MutPred
0.58
Gain of disorder (P = 0.106)
MVP
0.55
MPC
0.72
ClinPred
0.61
D
GERP RS
1.9
Varity_R
0.055
gMVP
0.047
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200779985; hg19: chr19-37210867; API